These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12808482

  • 1. Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven?
    Yusuf S, Camm AJ.
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):89-105. PubMed ID: 12808482
    [Abstract] [Full Text] [Related]

  • 2. Inappropriate sinus tachycardia in a heart transplant successfully treated with ivabradine.
    Mehta N, Bapat A, Tedrow U, Stevenson WG, Koplan B.
    Europace; 2017 Jul 01; 19(7):1100. PubMed ID: 28431002
    [No Abstract] [Full Text] [Related]

  • 3. Ivabradine in patients with inappropriate sinus tachycardia.
    Zellerhoff S, Hinterseer M, Felix Krull B, Schulze-Bahr E, Fabritz L, Breithardt G, Kirchhof P, Kääb S.
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec 01; 382(5-6):483-6. PubMed ID: 20859616
    [Abstract] [Full Text] [Related]

  • 4. Specific bradycardic agents--a novel pharmacological class?
    Kobinger W, Lillie C.
    Eur Heart J; 1987 Dec 01; 8 Suppl L():7-15. PubMed ID: 2897916
    [Abstract] [Full Text] [Related]

  • 5. Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockers.
    Lillie C, Kobinger W.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar 01; 335(3):331-3. PubMed ID: 3587375
    [Abstract] [Full Text] [Related]

  • 6. Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentration.
    Lillie C, Kobinger W.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec 01; 328(2):210-3. PubMed ID: 6527706
    [Abstract] [Full Text] [Related]

  • 7. Symptom improvement in postural orthostatic tachycardia syndrome with the sinus node blocker ivabradine.
    Ewan V, Norton M, Newton JL.
    Europace; 2007 Dec 01; 9(12):1202. PubMed ID: 17951266
    [No Abstract] [Full Text] [Related]

  • 8. Inappropriate sinus tachycardia: focus on ivabradine.
    Abed HS, Fulcher JR, Kilborn MJ, Keech AC.
    Intern Med J; 2016 Aug 01; 46(8):875-83. PubMed ID: 27059112
    [Abstract] [Full Text] [Related]

  • 9. The sinus tachycardias.
    Yusuf S, Camm AJ.
    Nat Clin Pract Cardiovasc Med; 2005 Jan 01; 2(1):44-52. PubMed ID: 16265342
    [Abstract] [Full Text] [Related]

  • 10. Alinidine as a model of the mode of action of specific bradycardic agents on SA node activity.
    van Ginneken AC, Bouman LN, Jongsma HJ, Duivenvoorden JJ, Opthof T, Giles WR.
    Eur Heart J; 1987 Dec 01; 8 Suppl L():25-33. PubMed ID: 3451880
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the bradycardic effects of alinidine (St 567), AQ-A 39 and verapamil on guinea-pig sinoatrial node superfused with different Ca2+ and NaCl solutions.
    Lillie C, Kobinger W.
    Eur J Pharmacol; 1983 Jan 28; 87(1):25-33. PubMed ID: 6840187
    [Abstract] [Full Text] [Related]

  • 12. Conventional management of inappropriate sinus tachycardia.
    Olshansky B, Sullivan RM.
    J Interv Card Electrophysiol; 2016 Jun 28; 46(1):43-5. PubMed ID: 26164138
    [Abstract] [Full Text] [Related]

  • 13. If channel blocker ivabradine vs. β-blockers for sinus tachycardia in patients with takotsubo syndrome.
    Madias JE.
    Int J Cardiol; 2016 Nov 15; 223():877-878. PubMed ID: 27584563
    [No Abstract] [Full Text] [Related]

  • 14. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK.
    Europace; 2013 Jan 15; 15(1):116-21. PubMed ID: 22772053
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of ivabradine in a case of inappropriate sinus tachycardia and ventricular dysfunction.
    Sette A, Martino A, Lioy E, Calò L.
    J Cardiovasc Electrophysiol; 2010 Jul 15; 21(7):815-7. PubMed ID: 20233274
    [Abstract] [Full Text] [Related]

  • 16. [Therapy of perioperative sinus tachycardia with the new calcium antagonist falipamil].
    Tryba M, Zenz M.
    Arzneimittelforschung; 1987 Nov 15; 37(11):1298-300. PubMed ID: 3440040
    [Abstract] [Full Text] [Related]

  • 17. Inappropriate sinus tachycardia.
    Olshansky B, Sullivan RM.
    Europace; 2019 Feb 01; 21(2):194-207. PubMed ID: 29931244
    [Abstract] [Full Text] [Related]

  • 18. Antiarrhythmic effects of verapamil.
    Singh BN, Nademanee K, Feld G.
    Angiology; 1983 Sep 01; 34(9):572-90. PubMed ID: 6351674
    [No Abstract] [Full Text] [Related]

  • 19. A summary of the acute effects of falipamil in man.
    Gülker H.
    Eur Heart J; 1987 Dec 01; 8 Suppl L():141-6. PubMed ID: 3330525
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments.
    Kaplinsky E, Comes FP, Urondo LS, Ayma FP.
    Cardiol J; 2010 Dec 01; 17(2):166-71. PubMed ID: 20544616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.